Welcome to the 2025 ISPE Biotechnology Conference
The 2025 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on the evolving landscape and future of the development and manufacturing of biotechnology products.
This conference will focus on unique challenges associated with innovative pharmaceutical products applied and transferred to the (new) biosimilar, bio better, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based product development and new applications. In addition, the conference will feature presentations with a focus on enablers for process intensification, speed-to-market, sustainability, product technology transfer, analytics and quality management, operational readiness, digital transformation, and manufacturing.
Conference Attendees
Navigate the conference platform via the listed links.
- Attendee Roster: View the full list of conference attendees - platform
- Presentation: Presentations received from speakers before the conference who have agreed to make them available are currently posted on the conference platform.
- Featured Speakers: View all session speakers
Featured Sessions
AI as an Enabler for a Sustainable Quality Transformation
Global Quality Takeda is reimagining our quality commitments across the value chain. By harnessing data, digital, and emerging technologies like AI, we aim to accelerate product delivery, foster a culture of learning and innovation, and ensure environmental sustainability. These examples highlight how AI can enable sustainable quality transformation.
Accelerating Biomanufacturing Modular Design & AI Impact
Biopharma companies are under intense pressure to bring progressively sophisticated production capacity online in ever-shorter timelines. This presentation will delve into the role that modular hardware and automation design frameworks are increasingly playing in helping meet this need, in particular by enabling the implementation of digitalization and sophisticated control strategies.
Predicting Stability of Biologics and Vaccines
The stability of biologics and vaccines is of great interest industries and government institutions. We used Arrhenius-based equations to fit the stability data obtained under recommended storage and accelerated conditions by computed kinetic parameters, and finally, to predict valuable the long term stability of vaccines and adjuvants. Ensuring ‘Good Modeling Practices’ the modeling approach combines advanced kinetic and statistical analysis to describe degradation rates of products as function of time and temperatures.
Critical Utilities Sustainability - Case Study
This presentation aims to show an overview of sustainability in clean utilities for the Facility of the Future-As a supplier of clean utilities systems, we will address end user needs in term of more sustainable technologies and process solutions.
Spread the Word on Social Media
Use this graphic, tag @ISPE, and include hashtags #ISPE #ISPEBiotech #ISPEBiotechnologyConference in your social posts. Don’t forget to follow these hashtags to stay updated on all the conference activities and events throughout the conference.
Thank You to Our Event Sponsors and Supporters
Thank You to Our Media Partners
